Persist AI
Biotechnology company combining AI and robotics for high-throughput pharmaceutical formulation development, focusing on long-acting injectables, amorphous solid dispersions, parenterals, creams, and in-situ depots.
About Persist AI
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
Products
Self-improving formulation AI deployed on customer IT infrastructure that predicts formulation, stability, PK, and process outcomes using data from the company’s robotic lab and...
Full-service preclinical formulation development leveraging AI models, robotics, and formulation expertise.
Service allowing customers to run experiments via a cloud portal on Persist AI’s robotic lab, with results streaming directly to dashboards and AI models.
What customers say
“Persist's high throughput formulation screening and AI-driven predictions are revolutionary.”
Security and compliance
No security details published yet
Persist AI hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Persist AI